These emerging therapies, including Rybelsus, belong to a category of drugs called GLP-1 agents. Initially developed for treating diabetes mellitus , they work by encouraging the body to release sufficient the hormone insulin and reducing high blood sugar levels. Furthermore , their ability to promote slimming has led to significant attention and b